Osteoblast and Osteoclast Markers
Bone homeostasis is dependent on the balance of deposition by osteoblasts and resorption by osteoclasts. This dynamic process is responsible for the continuous remodeling of bone tissue and is crucial for maintenance of bone size, shape, and integrity. Disruptions of bone homeostasis accompany disorders that include osteoporosis, arthritis, and many inheritable skeletal diseases. R&D Systems offers products that can be used as cell-type specific markers for osteoblasts (i.e. osteocalcin, DMP-1, osteoahderin) and osteoclasts (i.e. RANK, OSCAR, Calcitonin).
Cell Surface Osteoblast and Osteoclast Markers
- 5'-Nucleotidase/CD73
- ALCAM/CD166
- B220/CD45R
- Calcitonin and Related Receptor Agonists
- Calcitonin and Related Receptor Antagonists
- Calcitonin R
- CD44
- CD45
- CD90/Thy1
- CD45RA
- CD45RB
- CD45RO
- DC-STAMP
- GABA-B R1
- GABA-B Receptor Agonists
- GABA-B Receptor Antagonists
- GABA-B Receptor Modulators
- GABA B Receptor Compounds
- GABA Transporter Inhibitors
- Additional GABA Compounds
- Integrin alpha V/CD51
- OC-STAMP
- OSCAR
- PTH1R/PTHR1
- RANK/TNFRSF11A
Osteoblast and Osteoclast Markers - Intracellular
Secreted Osteoblast and Osteoclast Molecules
Related Information
- Activated T Cells Mediate Bone Loss Through OPGL/TRANCE
- Osteoclast Co-stimulation
- Mini-review: Calcium & Phosphorus Metabolism
- Human CD Marker Products
- Proinflammatory Cytokines & CCR2 Promote Estrogen-deficient Bone Loss
- Cytokine-mediated Bone Resorption in Rheumatoid Arthritis
- BIObrief: Cytokine-mediated Bone Resorption in Rheumatoid Arthritis
- Skeletal System Development
- Poster: Bone Resorption Schematic